ZOLL Medical Corporation Sustainability Profile
ZOLL Medical Corporation, a leading player in the medical technology industry, is headquartered in the United States. Founded in 1980, ZOLL has established itself as a pioneer in advanced resuscitation and critical care solutions, with a strong presence in North America and Europe. The company is renowned for its innovative products, including defibrillators, monitoring devices, and data management solutions, which enhance patient outcomes in emergency medical situations. ZOLL's commitment to quality and innovation has earned it a prominent market position, with notable achievements in improving survival rates through its cutting-edge technologies. The company’s unique approach combines advanced algorithms and user-friendly designs, setting it apart from competitors. With a focus on saving lives, ZOLL Medical Corporation continues to lead the way in the evolving landscape of emergency medical services and hospital care.
DitchCarbon Score
How does ZOLL Medical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ZOLL Medical Corporation's score of 70 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ZOLL Medical Corporation, headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Asahi Kasei Corporation, which may influence its climate commitments and emissions reporting. As part of its environmental strategy, ZOLL Medical Corporation inherits climate initiatives and performance metrics from its parent company, Asahi Kasei Corporation. However, no specific reduction targets or climate pledges have been documented for ZOLL Medical Corporation itself. The absence of detailed emissions data and reduction initiatives suggests that ZOLL Medical Corporation may still be in the process of establishing its own climate commitments or aligning with broader corporate sustainability goals set by Asahi Kasei Corporation. In summary, while ZOLL Medical Corporation is part of a larger corporate family with potential climate initiatives, specific emissions data and reduction targets for the company remain unspecified.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | 0,000,000,000 | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | - | 0,000,000,000 | - | - | - | - | - | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is ZOLL Medical Corporation's Industry?
How Carbon Intensive is ZOLL Medical Corporation's Location?
ZOLL Medical Corporation's Scope 3 Categories Breakdown
ZOLL Medical Corporation's Scope 3 emissions, which decreased by 0% last year and increased by approximately 113% since 2015, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 79% of total emissions under the GHG Protocol, with "End-of-Life Treatment of Sold Products" being the largest emissions source at 41% of Scope 3 emissions.
Top Scope 3 Categories
ZOLL Medical Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ZOLL Medical Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
